A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

HIGHLIGHTSAmplia’s lead drug narmafotinib enhances the activity of kRAS inhibitors in multiple preclinical cancer models presented at US ...

Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...

Among patients with no history of cancer, the tool achieved a prediction accuracy rate of 50%.

A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.

Pancreatic cancer is a very challenging disease. It’s tough to catch early, spreads rapidly, and doesn’t respond easily to treatment. This year, pancreatic cancer is expected to be the 12th most ...

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...